4th Risk-Based Quality Management - Dynamic Global Events

The clinical trial landscape has shifted as a result of COVID-19 and quality risk management techniques and tools have evolved by leaps and bounds over the last year. Best practices in RBQM are influencing clinical study methodology and decentralized trials, putting a spotlight on risk based data review including site and central monitoring.

DGE invites you to attend the 4^th Risk-Based Quality Management Summit and hear from industry experts on how elements of RBQM can be implemented individually and independently to great success, making clinical trials better, faster, cheaper, and safer for patients.

Featured Topics & Discussions

Enable Smarter RBQM with Technology
Review Newly Revised ICH E6(R3) and its Impact in Clinical Research
Evaluate Key Success Factors for Adopting a QbD Methodology
Predict and Avoid Common Pitfalls in Your RBQM Journey
Acquire Talent With the Necessary Skills for RBQM Success

Who Will Attend

This conference is designed for pharmaceutical, biotech, and medical device professionals responsible for:

RBM/RBQM
Study Monitoring
Central Monitoring/Site Monitoring
Clinical Operations
Clinical Research
Clinical Quality
Clinical Quality Assurance
Clinical Compliance
Clinical Outsourcing
Data Management
Data Science
Global Clinical Trial Operations
Regulatory Affairs
Risk Evaluation

Connect with industry leaders, expand your network, and benefit from exclusive access to industry updates. Discover new opportunities in a seamless, interactive learning environment. Elevate your experience with us!

Thank You To Our Sponsors

Maximize your brand's impact and visibility by becoming a valued sponsor. Shape the future of life sciences, connect with other industry leaders, and showcase your commitment to innovation. Elevate your presence - sponsor this conference and be at the forefront of advancements in science and technology.